AR132764A1 - TYK2 INHIBITORS AND THEIR USES - Google Patents
TYK2 INHIBITORS AND THEIR USESInfo
- Publication number
- AR132764A1 AR132764A1 ARP240101304A ARP240101304A AR132764A1 AR 132764 A1 AR132764 A1 AR 132764A1 AR P240101304 A ARP240101304 A AR P240101304A AR P240101304 A ARP240101304 A AR P240101304A AR 132764 A1 AR132764 A1 AR 132764A1
- Authority
- AR
- Argentina
- Prior art keywords
- tyk2 inhibitors
- compound
- pharmaceutically acceptable
- tyk2
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Un compuesto de fórmula (1). Una composición farmacéutica que comprende el compuesto de cualquiera de las reivindicaciones 1 - 56, o una sal, tautómero o solvato farmacéuticamente aceptable de este, y un excipiente farmacéuticamente aceptable.A compound of formula (1). A pharmaceutical composition comprising the compound of any one of claims 1-56, or a pharmaceutically acceptable salt, tautomer or solvate thereof, and a pharmaceutically acceptable excipient.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363504693P | 2023-05-26 | 2023-05-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR132764A1 true AR132764A1 (en) | 2025-07-30 |
Family
ID=91853738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP240101304A AR132764A1 (en) | 2023-05-26 | 2024-05-23 | TYK2 INHIBITORS AND THEIR USES |
Country Status (6)
| Country | Link |
|---|---|
| AR (1) | AR132764A1 (en) |
| AU (1) | AU2024279507A1 (en) |
| IL (1) | IL324864A (en) |
| MX (1) | MX2025014163A (en) |
| TW (1) | TW202511266A (en) |
| WO (1) | WO2024246599A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025207583A1 (en) * | 2024-03-26 | 2025-10-02 | V6 Therapeutics, Inc. | Selective jak2 inhibitors and uses thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL305165A (en) * | 2021-02-19 | 2023-10-01 | Sudo Biosciences Ltd | TYK2 inhibitors and their uses |
-
2024
- 2024-05-23 AU AU2024279507A patent/AU2024279507A1/en active Pending
- 2024-05-23 TW TW113119015A patent/TW202511266A/en unknown
- 2024-05-23 AR ARP240101304A patent/AR132764A1/en unknown
- 2024-05-23 WO PCT/IB2024/000251 patent/WO2024246599A1/en active Pending
-
2025
- 2025-11-23 IL IL324864A patent/IL324864A/en unknown
- 2025-11-26 MX MX2025014163A patent/MX2025014163A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2025014163A (en) | 2026-01-07 |
| TW202511266A (en) | 2025-03-16 |
| WO2024246599A1 (en) | 2024-12-05 |
| IL324864A (en) | 2026-01-01 |
| AU2024279507A1 (en) | 2025-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2022012975A2 (en) | Biaryl derivatives as inhibitors of yap/taz-tead protein-protein interaction | |
| AR132338A1 (en) | RAS INHIBITORS | |
| AR133988A1 (en) | RAS-PI3K INHIBITORS AND THEIR USES | |
| AR134265A1 (en) | HETEROCYCLES AND THEIR USES | |
| AR126251A1 (en) | CDK2 INHIBITORS | |
| AR131639A1 (en) | KIF18A INHIBITORS AND THEIR USES | |
| AR133619A1 (en) | TRIAZINE COMPOUNDS | |
| AR128932A1 (en) | BCL-XL INHIBITORS | |
| DOP2025000009A (en) | NOVEL ACC INHIBITORS | |
| AR132764A1 (en) | TYK2 INHIBITORS AND THEIR USES | |
| AR131906A1 (en) | THERAPEUTIC COMPOUNDS | |
| AR130828A1 (en) | METHOD FOR TREATING CANCER | |
| CL2022002490A1 (en) | Biaryl derivatives as inhibitors of yap/taz-tead protein-protein interaction | |
| AR132983A1 (en) | KEAP1 INHIBITORS AND THEIR USES | |
| AR132905A1 (en) | Selective bifunctional degraders of SMARCA2 and their therapeutic uses | |
| AR130303A1 (en) | PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR THERAPEUTIC USE | |
| AR134491A1 (en) | TYK2 INHIBITORS AND THEIR USES | |
| AR129460A1 (en) | INDOLIZINE DERIVATIVES FOR TREATMENT OF TRPM3-MEDIATED DISORDERS | |
| AR134206A1 (en) | DEGRADATORS AND THEIR USES | |
| AR124982A1 (en) | MACROCYCLES AND THEIR USES | |
| AR134110A1 (en) | RAS INHIBITORS | |
| AR133489A1 (en) | FUSED PYRIDINES FOR THE TREATMENT OF CANCER AND OTHER INDICATIONS | |
| AR131855A1 (en) | Cyclin-dependent kinase inhibitors (CDK2) | |
| AR132601A1 (en) | PYRIDOPYRIMIDINE DERIVATIVES AND THEIR USES | |
| AR128896A1 (en) | IKZF2 DEGRADERS AND USES OF THESE |